Serum Concentrations of Mannan-Binding Lectin (MBL) and MBL-Associated Serine Protease-2 and the Risk of Adverse Events in Pediatric Patients With Cancer and Fever in Neutropenia.

MLA

Ammann, Roland A., et al. “Serum Concentrations of Mannan-Binding Lectin (MBL) and MBL-Associated Serine Protease-2 and the Risk of Adverse Events in Pediatric Patients With Cancer and Fever in Neutropenia.” Journal of the Pediatric Infectious Diseases Society, vol. 2, no. 2, June 2013, pp. 155–61. EBSCOhost, https://doi.org/10.1093/jpids/pit005.

APA

Ammann, R. A., Bodmer, N., Simon, A., Agyeman, P., Leibundgut, K., Schlapbach, L. J., & Niggli, F. K. (2013). Serum Concentrations of Mannan-Binding Lectin (MBL) and MBL-Associated Serine Protease-2 and the Risk of Adverse Events in Pediatric Patients With Cancer and Fever in Neutropenia. Journal of the Pediatric Infectious Diseases Society, 2(2), 155–161. https://doi.org/10.1093/jpids/pit005

Chicago

Ammann, Roland A, Nicole Bodmer, Arne Simon, Philipp Agyeman, Kurt Leibundgut, Luregn J Schlapbach, and Felix K Niggli. 2013. “Serum Concentrations of Mannan-Binding Lectin (MBL) and MBL-Associated Serine Protease-2 and the Risk of Adverse Events in Pediatric Patients With Cancer and Fever in Neutropenia.” Journal of the Pediatric Infectious Diseases Society 2 (2): 155–61. doi:10.1093/jpids/pit005.